Clinical evidence-based evaluation of Traditional Chinese Medicine for prevention and treatment of diabetic high-risk foot

Hospital of Chengdu University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the diagnostic criteria for type 2 diabetes defined in the Guideline for the prevention and treatment of type diabetes mellitus in China (2020 edition);
•2.Meet the diagnostic criteria for high-risk foot for diabetes;
•3.Age between 18 and 80 years old, regardless of gender;
•4.Voluntarily participate in this trial and sign the informed consent.

•1. Patients with typical diabetic foot symptoms such as foot ulcers, infections, and gangrene;
•2.There are other diseases that cause damage to peripheral nerves and blood vessels;
•3.Mentally ill patients;
•4.Combined with serious heart, brain, kidney and other complications, or combined with other serious primary diseases;
•5.Those who have a history of allergies or allergies to drugs, food, pollen, etc.;
•6.Pregnant, lactating women and women planning to become pregnant;
•7.Those who use hormones and undergo surgical treatment and other stressful states of the body;
•8.Patients with acute diabetic complications such as ketoacidosis and hyperosmolarity and concurrent infections;
•9.Patients who use antioxidant drugs (such as lipoic acid), anti-platelet aggregation drugs (such as aspirin enteric-coated tablets), Chinese patent medicines and other nerve and vascular disease prevention drugs and nutritional nerve preparations (such as methylcobalamin);
•10.Those who have participated in other clinical trials within three months.
•Note: Patients who meet any of the above should be excluded.

发起方

Hospital of Chengdu University of TCM